CASI Pharmaceuticals, Inc (DE) Quarterly Operating Margin in % from Q4 2019 to Q4 2022

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
CASI Pharmaceuticals, Inc (DE) quarterly/annual Operating Margin history and growth rate from Q4 2019 to Q4 2022.
  • CASI Pharmaceuticals, Inc (DE) Operating Margin for the quarter ending December 31, 2022 was -79 %, a 42.6% increase year-over-year.
  • CASI Pharmaceuticals, Inc (DE) annual Operating Margin for 2022 was -79 %, a 42.6% increase from 2021.
  • CASI Pharmaceuticals, Inc (DE) annual Operating Margin for 2021 was -138 %, a 60.5% increase from 2020.
  • CASI Pharmaceuticals, Inc (DE) annual Operating Margin for 2020 was -349 %, a 69.3% increase from 2019.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q4 2022 -79 +58.7 +42.6% Oct 1, 2022 Dec 31, 2022
Q3 2022 -87.7 +94 +51.8% Jul 1, 2022 Sep 30, 2022
Q2 2022 -94.5 +173 +64.7% Apr 1, 2022 Jun 30, 2022
Q1 2022 -99.2 +242 +70.9% Jan 1, 2022 Mar 31, 2022
Q4 2021 -138 +211 +60.5% Oct 1, 2021 Dec 31, 2021
Q3 2021 -182 +234 +56.3% Jul 1, 2021 Sep 30, 2021
Q2 2021 -267 +129 +32.6% Apr 1, 2021 Jun 30, 2021
Q1 2021 -341 +288 +45.8% Jan 1, 2021 Mar 31, 2021
Q4 2020 -349 +788 +69.3% Oct 1, 2020 Dec 31, 2020
Q3 2020 -416 Jul 1, 2020 Sep 30, 2020
Q2 2020 -397 Apr 1, 2020 Jun 30, 2020
Q1 2020 -629 Jan 1, 2020 Mar 31, 2020
Q4 2019 -1.14K Oct 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.